Evans Gray C

Novavax, Inc.

Director

Avg. Two Year Performance

41% Avg. Purchase Return 19% Compound

5% Avg. Sale Return 3% Compound

Holdings: 19.55K shares

Last Three Months: 20-Feb-24 -- 19-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

20-May-22 -- 19-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions